Akili

Biotechnology ResearchMassachusetts, United States51-200 Employees

Akili is a mid-sized biotechnology research company based in Boston, Massachusetts, focused on developing digital medicines delivered through engaging video game experiences rather than traditional pills. The approach combines neuroscience with game development to address cognitive deficits and the symptoms associated with neurological and psychiatric conditions. The firm maintains a broad pipeline targeting cognitive function across conditions including ADHD, major depressive disorder, autism spectrum disorder, and various inflammatory diseases.

One notable recent development is the U.S. FDA's June 2024 clearance of EndeavorOTC, an over-the-counter digital treatment for adults with ADHD delivered via a video game. Akili states it continually evaluates new technologies and seeks to advance its programs in neurology and psychiatry.

Sign up for free to view info

Email Format Employee directory